Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SANA

Sana Biotechnology Inc

Jun 10 • 04:00PM ET

2.82

0.00 0.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RYTM KYMR NUVL BMRN INCY VKTX KRYS AXSM MDGL NBIX

| Held by: XBI VTI IWM VXF IBB IWN VTWO SCHA VHT PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.94	Insider Own	34.92%	Shs Outstand	269.82M	Perf Week	-9.62%
Market Cap	784.78M	Forward P/E	-	EPS next Y	-0.58	Insider Trans	0.00%	Shs Float	181.10M	Perf Month	-20.79%
Enterprise Value	754.78M	PEG	-	EPS next Q	-0.15	Inst Own	54.04%	Short Float	21.72%	Perf Quarter	-10.48%
Income	-241.99M	P/S	-	EPS this Y	36.26%	Inst Trans	0.81%	Short Ratio	10.42	Perf Half Y	-39.09%
Sales	0.00M	P/B	6.38	EPS next Y	5.75%	ROA	-59.09%	Short Interest	39.33M	Perf YTD	-30.71%
Book/sh	0.44	P/C	7.45	EPS next 5Y	14.86%	ROE	-147.41%	52W High	6.55 -56.95%	Perf Year	-3.09%
Cash/sh	0.38	P/FCF	-	EPS past 3/5Y	12.33% 8.72%	ROIC	-134.67%	52W Low	2.41 17.01%	Perf 3Y	-54.52%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.45% 7.22%	Perf 5Y	-88.75%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-6.15%	Oper. Margin	-	ATR (14)	0.22	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.29	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	38.40	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	1.29	EPS Q/Q	17.99%	SMA20	-7.42%	Beta	2.17	Target Price	9.50
Payout	-	Debt/Eq	0.63	Sales Q/Q	-	SMA50	-12.80%	Rel Volume	0.71	Prev Close	2.82
Employees	142	LT Debt/Eq	0.51	Earnings	May 11 AMC	SMA200	-26.61%	Avg Volume	3.77M	Price	2.82
IPO	Feb 04, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.00% -	Trades		Volume	2,679,772	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)